The observed increased levels of Fabp4 is related to the development of non-alcoholic fatty liver disease (NAFLD) [41,42,43], which involves Cd36 expression as a potential marker, and hepatic lipotoxicity [44,45]. The gene discussed is CD36; the disease is metabolic dysfunction-associated steatotic liver disease.